Eszopiclone

Back to search

Molecule Structure

Scientific Name

Eszopiclone

Description of the Drug

Eszopiclone is a sedative-hypnotic used in the treatment of insomnia, improving both the latency phase and the maintenance phase of sleep.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00402

Brand Name(s)

Eszopiclone, Lunesta

Company Owner(s)

Nostrum Laboratories Inc, Mylan Pharmaceuticals Inc, Hikma Pharmaceuticals Usa Inc, Orchid Healthcare, Macleods Pharmaceuticals Ltd, Glenmark Generics Ltd, Sunovion Pharmaceuticals Inc, Dr Reddys Laboratories Ltd, Wockhardt Ltd, Lupin Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
GABA-A receptor; anion channel PROTEIN COMPLEX GROUP POSITIVE ALLOSTERIC MODULATOR CHEMBL2093872

Unichem Links

SureChEMBL SCHEMBL28657
PharmGKB PA162630444
Human Metabolome Database HMDB0014546
DrugBank DB00402
PubChem: Thomson Pharma 14927588
PubChem 969472
Mcule MCULE-5099990703 MCULE-3167182309
Nikkaji J573.434G
EPA CompTox Dashboard DTXSID8046086
DrugCentral 1068
ChemicalBook CB1468825
Guide to Pharmacology 7429
GSRS f2d65111-ecbc-45fb-b51e-6753757e6511
rxnorm LUNESTA ESZOPICLONE
PubChem: Drugs of the Future 12015386
ChEBI 53760
NIH Clinical Collection SAM002548982
ZINC ZINC000019632834